In recent years, the Department of Cardiovascular Medicine of our hospital has proposed from the pathogenesis that ischemic cardiovascular disease is a pair of oogenic brothers, with the heart and brain being homologous and the root of the disease being in the blood vessels. The initiating factors of vascular lesions are endothelial dysfunction, endothelial damage, hyperlipidemia, hypercoagulability, lipid deposition leading to progressive atherosclerosis, plaque formation, plaque rupture, and then thrombosis leading to myocardial infarction or cerebral infarction. The three drugs (aspirin, simvastatin and tongxinluo) with anticoagulation, lipid regulation and stabilization of vascular endothelial function, which can play a synergistic and additive role in combination, should be used as the cornerstone of the prevention and treatment of cardiovascular and cerebrovascular diseases, regardless of outpatient and ward application, with satisfactory prevention and treatment effects. In March this year, at the “Summit Forum on Progress in Prevention and Treatment of Ischemic Cardiovascular and Cerebrovascular Diseases” held in Beijing, famous medical experts in China proposed the “Golden Triangle” program for the first time for the prevention and treatment of cardiovascular and cerebrovascular diseases, that is, the combination of statins, aspirin and Tongxinluo capsules. The combination of statins, aspirin, and cardiac capsules, with simvastatin being the first choice. This is in line with what we have been thinking and doing for years. Experts agree that the key to preventing and treating cardiovascular disease lies in primary and secondary prevention. Primary prevention is to prevent the onset of cardiovascular disease in high-risk groups who have not suffered from it, while secondary prevention is to take preventive and curative measures for patients who have already suffered from cardiovascular disease and to prevent the recurrence of myocardial infarction or cerebral infarction in patients who have already suffered from it. Both primary and secondary prevention involve long-term use of lipid-lowering statins, anticoagulant aspirin and Tongxinluo capsules. The combination of Tongxinluo and statins can enhance the lipid-lowering effect, and the combination with aspirin can enhance the anticoagulation and blood viscosity reduction efficacy, and also significantly improve aspirin resistance. According to statistics, 24% of patients who take aspirin for a long time are ineffective, which is aspirin resistance, while taking Tongxinluo at the same time can continue to let aspirin work. Many research data at home and abroad show that, compared with statins and aspirin, Tongxinluo capsule can not only lower lipid, anticoagulation, anti-inflammation and protect vascular endothelium, but also release cardiovascular spasm, inhibit the formation of plaque in blood vessels and stabilize plaque that is easy to rupture, prevent restenosis of blood vessels after stenting and thrombolysis, and protect and regenerate microvessels in ischemic area, so it can not only prevent cardiovascular disease, but also It can effectively treat coronary angina, myocardial ischemia, and sequelae of cerebral infarction, etc. The combination of statins, aspirin and Tongxinluo capsules constitutes the “Golden Triangle” program for the prevention and treatment of cardiovascular and cerebrovascular diseases. The “Golden Triangle” program has three main features: firstly, it protects the endothelium of blood vessels and repairs the damaged endothelium; secondly, it inhibits the formation of atheromatous plaques in blood vessels and stabilizes the easily ruptured plaques; thirdly, it prevents sudden attacks of cardiovascular and cerebrovascular diseases and prevents the restenosis of blood vessels and the recurrence of heart attack and cerebral infarction. The “Golden Triangle” program can not only achieve primary prevention for people at high risk of cardiovascular and cerebrovascular diseases, but also secondary prevention for patients who have already suffered from cardiovascular and cerebrovascular diseases, especially those who have suffered from myocardial infarction and cerebral infarction. The “Golden Triangle” program is not only a prevention program, but also a program for the treatment of myocardial ischemia, angina pectoris, heart attack and cerebral infarction of coronary heart disease. The “Golden Triangle” program is a program to prevent cardiovascular diseases before they occur, to prevent them from changing, and to prevent recurrence after they occur.